Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Infectious Diseases Now|May 15, 2021
Restricted antimicrobial prescribing in an area of highly prevalent antimicrobial resistanceMichael Samarkos, Marina Skouloudi, Amalia Anastasopoulou, et al.Mycoses|May 28, 2020
Non-Aspergillus invasive mould infections in patients treated with ibrutinibAmalia Anastasopoulou, Adam J DiPippo, Dimitrios P KontoyiannisJCEM Case Reports|May 13, 2025
An Extremely Rare Case of Immune Checkpoint Inhibitors-Related Hypoparathyroidism and a Critical Literature ReviewSpyridon Kazanas, Amalia Anastasopoulou, Dimitrios Ziogas, et al.Journal of Fungi (Basel, Switzerland)|November 10, 2022
Acute Lymphoblastic Leukemia and Invasive Mold Infections: A Challenging FieldChristos Stafylidis, Panagiotis Diamantopoulos, Eleni Athanasoula, et al.Journal of Fungi (Basel, Switzerland)|August 2, 2018
Therapy of MucormycosisNikolaos V Sipsas, Maria N Gamaletsou, Amalia Anastasopoulou, et al.Melanoma Research|March 26, 2026
Immune-related cholecystitis following combination therapy with nivolumab and ipilimumab in a patient with metastatic melanoma: a case report and literature reviewAikaterini Gkoufa, Amalia Anastasopoulou, Georgia Sypsa, et al.Melanoma Research|September 1, 2018
Incomplete Vogt-Koyanagi-Harada disease following treatment with encorafenib and binimetinib for metastatic melanomaPanagiotis T Diamantopoulos, Sofia Stoungioti, Amalia Anastasopoulou, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 13, 2017
Inflammatory Myopathy and Axonal Neuropathy in a Patient With Melanoma Following Pembrolizumab TreatmentPanagiotis T Diamantopoulos, Katerina Tsatsou, Olga Benopoulou, et al.Therapeutic Advances in Hematology|March 20, 2023
Challenges in the treatment of melanoma with BRAF and MEK inhibitors in patients with sickle cell disease: case report and review of the literaturePanagiotis T Diamantopoulos, Amalia Anastasopoulou, Maria Dimopoulou, et al.Medicine|March 10, 2020
A case report of immune-mediated arthritis in a patient with cutaneous melanoma receiving checkpoint inhibition therapyGeorge Papaxoinis, Amalia Anastasopoulou, Katerina Laskari, et al.Pageof 5